General Information


DRAVPR ID  DRAVPR0051

Name   Cyanovirin-N

Sequence 

Sequence Length  101

Source  Nostoc ellipsosporum

UniProt ID P81180

Gene N/A



Activity Information


Target Organism  HIV

Activity 

  • [Ref.20162270]Human immunodeficiency virus(HIV):CVN is effective against most HIV strains with an EC50 of less than 1 nM.



Structure Information


PDB ID  1LOM  2RDK  3CZZ  4J4C  6X7H 

Predicted Structure Download  AF-P81180-F1

';

Modification  There are two disulfide bonds between Cys8 and Cys22, Cys58 and Cys73.



Comment


Elevated cellular levels of human BST-2 inhibited the release of virus-like particles (VLPs) consisting of the matrix proteins of multiple highly virulent NIAID Priority Pathogens, including arenaviruses (LASV and Machupo virus [MACV]), filoviruses (ZEBOV and MARV), and paramyxoviruses (Nipah virus). However, filoviruses, RVFV, and CPXV are immune to the inhibitory effect of BST-2.



Literature Information


Literature 1

Title   The antiviral protein cyanovirin-N: the current state of its production and applications.

Pubmed ID   20162270

Author   Xiong S, Fan J, Kitazato K.